Characteristics of patients with end stage CF
| End stage CF patients from whom an NTM culture was obtained(N = 132) | End stage CF patients with NTM isolates(N = 26) | End stage CF patients without NTM isolates(N = 106) | p value* | |
|---|---|---|---|---|
| Data are shown as mean (SD) or n (%). | ||||
| NTM, non-tuberculous mycobacteria; FVC, forced vital capacity; FEV1, forced expiratory volume in 1 second; BMI, body mass index. | ||||
| *End stage CF patients with NTM isolates v end stage CF patients without NTM isolates. | ||||
| Age (years) | 27.3 (9.1) | 28.5 (9.4) | 27.1 (9.1) | 0.48 |
| Sex (female) | 61 (46%) | 12 (46%) | 49 (45%) | 0.92 |
| FVC (l) | 1.86 (0.70) | 1.98 (0.74) | 1.83 (0.69) | 0.36 |
| FVC (%) | 46.3 (12.6) | 49.1 (14.1) | 45.5 (12.0) | 0.27 |
| FEV1 (l) | 0.92 (0.33) | 0.98 (0.32) | 0.90 (0.34) | 0.29 |
| FEV1 (%) | 26.8 (8.8) | 28.6 (7.7) | 26.4 (9.0) | 0.24 |
| BMI (kg/m2) | 18.2 (3.0) | 18.0 (2.5) | 18.2 (3.1) | 0.68 |
| Pseudomonas aeruginosa | 100 (76%) | 19 (73%) | 81 (76%) | 0.73 |
| Burkholderia cepacia | 25 (19%) | 6 (23%) | 19 (18%) | 0.58 |
| Staphylococcus aureus | 68 (51%) | 9 (42%) | 59 (56%) | 0.23 |